Number 6,in the second at Rosehill would be a better bet than options in companies that trade for less than 5 cents.Most of those companies will not be here in 2 years.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
